Inventor · disambiguated record
Kostantinos (Kostas) Kosmatopoulos
Also filed as: KOSMATOPOULOS KOSTANTINOS · KOSMATOPOULOS KOSTANTINOS (KOSTAS)
6 granted patents·6 pending applications·19 citations·filing 2005–2024
79Inventor score
Top patents by PatentIndex Score
12 records- 0183US8900600B2Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapyKOSMATOPOULOS KOSTANTINOS KOSTAS·Filed 2009·Granted Dec 2, 2014·4 cites·4 claims
- 0278US10024868B2Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapyKOSMATOPOULOS KOSTANTINOS KOSTAS·Filed 2009·Granted Jul 17, 2018·5 cites·9 claims
- 0378US8465747B2Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapyKOSMATOPOULOS KOSTANTINOS KOSTAS·Filed 2007·Granted Jun 18, 2013·4 cites·19 claims
- 0476US8663645B2Use of native peptides and their optimized derivatives for vaccinationKOSMATOPOULOS KOSTANTINOS KOSTAS·Filed 2006·Granted Mar 4, 2014·1 cites·9 claims
- 0566US12048737B2Use of a vaccine targeting a cryptic tert epitope, for treating cancer in a HLA-A*0201-positive patient having a non-immunogenic tumor expressing tertKRIPTIC PHARMACEUTICALS LTD·Filed 2018·Granted Jul 30, 2024·1 cites·12 claims
- 0665US7973128B2Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereofVAXON BIOTECH·Filed 2005·Granted Jul 5, 2011·4 cites·21 claims
- 0760US2024325511A1Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing TertKRIPTIC PHARMACEUTICALS LTD·Filed 2024·Application pending·0 cites
- 0852US2014178421A1Use of Native Peptides and Their Optimized Derivatives For VaccinationVAXON BIOTECH·Filed 2013·Application pending·0 cites
- 0946US2013266598A1Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For ImmunotherapyVAXON BIOTECH·Filed 2013·Application pending·0 cites
- 1043US2022249642A1Combination of Markers for Predicting the Response to Vx-001VAXON BIOTECH·Filed 2020·Application pending·0 cites
- 1143US2017202936A1Identification, Optimization And Use Of Cryptic HLA-B7 Epitopes For ImmunotherapyVAXON BIOTECH·Filed 2017·Application pending·0 cites
- 1240US2020079819A1Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Lung Cancer in a HLA-A*0201-Positive Never-Smoker or Light-Former Smoker PatientVAXON BIOTECH·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kostantinos (Kostas) Kosmatopoulos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →